HES
66
3
OI
43
-2
EQT
57
-3
XEL
65
-2
PNR
74
5
REGN
42
-2
EW
32
3
HCP
70
-4
SLB
56
-3
MMM
42
5
EMN
50
-2
PG
50
2
FLR
48
3
MA
67
-5
CTSH
65
-3
QCOM
55
-2
AIZ
78
2
SCHW
65
-2
FRT
48
2
PFG
50
-2
HES
66
3
OI
43
-2
EQT
57
-3
XEL
65
-2
PNR
74
5
REGN
42
-2
EW
32
3
HCP
70
-4
SLB
56
-3
MMM
42
5
EMN
50
-2
PG
50
2
FLR
48
3
MA
67
-5
CTSH
65
-3
QCOM
55
-2
AIZ
78
2
SCHW
65
-2
FRT
48
2
PFG
50
-2
Financhill
Back

SPDR® S&P Pharmaceuticals ETF Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
67

XPH
SPDR® S&P Pharmaceuticals ETF

Last Price:
46.28
Seasonality Move:
4.28%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

SPDR® S&P Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, SPDR® S&P Pharmaceuticals ETF has on average historically risen by 7.5% based on the past 18 years of stock performance.
  • SPDR® S&P Pharmaceuticals ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%
  • Is SPDR® S&P Pharmaceuticals ETF Stock Undervalued?
    The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $47.16. The Score for XPH is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • XPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will SPDR® S&P Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR® S&P Pharmaceuticals ETF has on average historically risen by 7.5% based on the past 18 years of stock performance.

SPDR® S&P Pharmaceuticals ETF Stock Rating

Buy
67
SPDR® S&P Pharmaceuticals ETF (XPH) is a Buy

Is SPDR® S&P Pharmaceuticals ETF overpriced?

  • SPDR® S&P Pharmaceuticals ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%

SPDR® S&P Pharmaceuticals ETF Stock Price History

Is XPH stock going to rise?

  • The current trend is moderately bearish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
48.76
52-Week Low:
35.82

Prediction Charts

Market Cap:
0
Price in USD:
47.16
Volume:
11.81K
Beta:
0.80

Technical Analysis

SMA50:
45.28
SMA100:
43.72
SMA200:
42.75
52-Wk Change:
33.98%

Stock Predictions

  • Is SPDR® S&P Pharmaceuticals ETF stock public?
    Yes, SPDR® S&P Pharmaceuticals ETF is a publicly traded company.
  • What is the SPDR® S&P Pharmaceuticals ETF stock quote today?
    The SPDR® S&P Pharmaceuticals ETF stock price is 47.16 USD today.
  • How to buy SPDR® S&P Pharmaceuticals ETF stock online?
    You can buy SPDR® S&P Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 46.01 45.67 46.20 45.67
Oct-28 46.00 46.40 46.60 46.00
Oct-29 46.36 46.54 46.58 46.25
Oct-30 46.20 46.41 46.79 46.20
Oct-31 46.08 46.00 46.29 45.71
Nov-1 46.25 46.16 46.33 46.11
Nov-4 46.03 45.98 46.30 45.88
Nov-5 45.82 46.34 46.34 45.51
Nov-6 47.00 47.07 47.65 46.85
Nov-7 47.30 47.64 47.87 47.30
Nov-8 47.62 48.05 48.26 47.31
Nov-11 48.70 48.29 48.76 48.29
Nov-12 48.06 47.48 48.18 47.48
Nov-13 47.72 47.16 47.88 47.08

SPDR® S&P Pharmaceuticals ETF Earnings

Data Unavailable

SPDR® S&P Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* SPDR® S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.